Status: current, Defined. Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3521409011 | Product containing ibritumomab tiuxetan (medicinal product) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 3715239013 | Ibritumomab tiuxetan-containing product | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Ibritumomab tiuxetan-containing product | Plays role | Antineoplastic therapeutic role | true | Inferred relationship | Some | ||
| Ibritumomab tiuxetan-containing product | Is a | Monoclonal antibody antineoplastic agent | true | Inferred relationship | Some | ||
| Ibritumomab tiuxetan-containing product | Is a | Monoclonal antibody-containing product | false | Inferred relationship | Some | ||
| Ibritumomab tiuxetan-containing product | Has active ingredient | Ibritumomab tiuxetan | true | Inferred relationship | Some | 1 | |
| Ibritumomab tiuxetan-containing product | Has active ingredient | Monoclonal antibody | false | Inferred relationship | Some | ||
| Ibritumomab tiuxetan-containing product | Is a | Antineoplastic agent | false | Inferred relationship | Some | ||
| Ibritumomab tiuxetan-containing product | Has active ingredient | Antineoplastic agent | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Ibritumomab tiuxetan only product | Is a | True | Ibritumomab tiuxetan-containing product | Inferred relationship | Some | |
| Ibritumomab tiuxetan 3.2mg injection solution 2mL vial | Is a | False | Ibritumomab tiuxetan-containing product | Inferred relationship | Some | |
| Ibritumomab tiuxetan | Is a | False | Ibritumomab tiuxetan-containing product | Inferred relationship | Some | |
| Ibritumomab tiuxetan 1.6mg/mL radiopharmaceutical infusion kit | Is a | False | Ibritumomab tiuxetan-containing product | Inferred relationship | Some | |
| Ibritumomab tiuxetan 3.2mg injection solution 2mL vial | Is a | False | Ibritumomab tiuxetan-containing product | Inferred relationship | Some |
This concept is not in any reference sets
FHIR